Postmortem Metabolomics of Insulin Intoxications and the Potential Application to Find Hypoglycemia-Related Deaths
暂无分享,去创建一个
[1] C. Aguilar-Salinas,et al. Metabolomic markers of glucose regulation after a lifestyle intervention in prediabetes , 2022, BMJ Open Diabetes Research & Care.
[2] F. Farzadfar,et al. Metabolic signatures of insulin resistance in non-diabetic individuals , 2022, BMC Endocrine Disorders.
[3] D. Wishart,et al. Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials , 2022, Pharmacological Reviews.
[4] F. Farzadfar,et al. Targeted metabolomics analysis of amino acids and acylcarnitines as risk markers for diabetes by LC–MS/MS technique , 2022, Scientific Reports.
[5] R. Zoja,et al. Postmortem forensic toxicology cases: A retrospective review from Milan, Italy , 2022, Journal of forensic sciences.
[6] H. Gréen,et al. Postmortem Metabolomics Reveal Acylcarnitines as Potential Biomarkers for Fatal Oxycodone-Related Intoxication , 2022, Metabolites.
[7] E. d’Aloja,et al. Infant urinary metabolomic profile in a fatal acute methadone intoxication , 2022, International Journal of Legal Medicine.
[8] H. Gréen,et al. The Importance of BHB Testing on the Post-Mortem Diagnosis of Ketoacidosis , 2021, Biomolecules.
[9] E. d’Aloja,et al. Looking for Post-Mortem Metabolomic Standardization: Waiting for Godot-The Importance of Post-Mortem Interval in Forensic Metabolomics. , 2021, Chemical research in toxicology.
[10] E. d’Aloja,et al. Metabolomics improves the histopathological diagnosis of asphyxial deaths: an animal proof-of-concept model , 2021, Scientific Reports.
[11] H. Gréen,et al. Post-Mortem Metabolomics: A Novel Approach in Clinical Biomarker Discovery and a Potential Tool in Death Investigations. , 2021, Chemical research in toxicology.
[12] A. Krętowski,et al. Applications of Metabolomics in Forensic Toxicology and Forensic Medicine , 2021, International journal of molecular sciences.
[13] M. Bohnert,et al. Metabolomics in postmortem cerebrospinal fluid diagnostics: a state-of-the-art method to interpret central nervous system–related pathological processes , 2020, International Journal of Legal Medicine.
[14] D. Wescott,et al. Postmortomics: The Potential of Untargeted Metabolomics to Highlight Markers for Time Since Death , 2020, Omics : a journal of integrative biology.
[15] E. Tai,et al. Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic Asian population , 2020, BMJ open diabetes research & care.
[16] T. Zeller,et al. Long-Chain Acylcarnitines and Cardiac Excitation-Contraction Coupling: Links to Arrhythmias , 2020, Frontiers in Physiology.
[17] V. P. Novoselov,et al. Post-mortem changes in metabolomic profiles of human serum, aqueous humor and vitreous humor , 2020, Metabolomics.
[18] T. Kraemer,et al. Postmortem metabolomics: Correlating time-dependent concentration changes of xenobiotic and endogenous compounds. , 2020, Drug testing and analysis.
[19] Xilin Yang,et al. The Association Between Acylcarnitine Metabolites and Cardiovascular Disease in Chinese Patients With Type 2 Diabetes Mellitus , 2020, Frontiers in Endocrinology.
[20] L. Fanton,et al. Is insulin intoxication still the perfect crime? Analysis and interpretation of postmortem insulin: review and perspectives in forensic toxicology , 2020, Critical reviews in toxicology.
[21] O. Melander,et al. Purine Metabolites and Carnitine Biosynthesis Intermediates Are Biomarkers for Incident Type 2 Diabetes , 2019, The Journal of clinical endocrinology and metabolism.
[22] Ruonan Wang,et al. Profile of cardiac lipid metabolism in STZ-induced diabetic mice , 2018, Lipids in Health and Disease.
[23] E. Ingelsson,et al. Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance , 2018, Scientific Reports.
[24] E. Liepinsh,et al. Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues , 2017, Scientific Reports.
[25] E. Liepinsh,et al. Acute and long‐term administration of palmitoylcarnitine induces muscle‐specific insulin resistance in mice , 2017, BioFactors.
[26] N. Secher,et al. Liver and Muscle Contribute Differently to the Plasma Acylcarnitine Pool During Fasting and Exercise in Humans. , 2016, The Journal of clinical endocrinology and metabolism.
[27] Dolores Corella,et al. Plasma acylcarnitines and risk of cardiovascular disease: effect of Mediterranean diet interventions. , 2016, The American journal of clinical nutrition.
[28] C. Aguilar-Salinas,et al. Metabolomics in diabetes, a review , 2016, Annals of medicine.
[29] N. Sunderland,et al. Fatal Insulin Overdoses: Case Report and Update on Testing Methodology , 2016, Journal of forensic sciences.
[30] R. McPherson,et al. Acylcarnitines: potential implications for skeletal muscle insulin resistance , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] S. Toennes,et al. Factors leading to the degradation/loss of insulin in postmortem blood samples. , 2014, Forensic science international.
[32] E. Liepinsh,et al. Long-chain acylcarnitine content determines the pattern of energy metabolism in cardiac mitochondria , 2014, Molecular and Cellular Biochemistry.
[33] Hui Sun,et al. Metabolomics in diabetes. , 2014, Clinica chimica acta; international journal of clinical chemistry.
[34] M. Copetti,et al. Metabolomics signature improves the prediction of cardiovascular events in elderly subjects. , 2014, Atherosclerosis.
[35] M. Graber. The incidence of diagnostic error in medicine , 2013, BMJ quality & safety.
[36] L. Ström,et al. Liquid chromatography/time-of-flight mass spectrometry analysis of postmortem blood samples for targeted toxicological screening , 2013, Analytical and Bioanalytical Chemistry.
[37] F. Vaz,et al. Acylcarnitines: reflecting or inflicting insulin resistance? , 2013, Diabetes.
[38] Nele Friedrich,et al. Metabolomics in diabetes research. , 2012, The Journal of endocrinology.
[39] R. Wanders,et al. Characterization of D-3-hydroxybutyrylcarnitine (ketocarnitine): an identified ketosis-induced metabolite. , 2012, Metabolism: clinical and experimental.
[40] F. Toledo,et al. Increased Levels of Plasma Acylcarnitines in Obesity and Type 2 Diabetes and Identification of a Marker of Glucolipotoxicity , 2010, Obesity.
[41] C. Hoppel,et al. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. , 2009, The Journal of nutrition.
[42] H Druid,et al. Postmortem identification of hyperglycemia. , 2009, Forensic science international.
[43] Ken-ichi Yoshida,et al. Biochemical blood markers and sampling sites in forensic autopsy. , 2008, Journal of forensic and legal medicine.
[44] Olga Ilkayeva,et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. , 2008, Cell metabolism.
[45] Nigel W. Hardy,et al. Proposed minimum reporting standards for chemical analysis , 2007, Metabolomics.
[46] O. Fiehn. Metabolomics – the link between genotypes and phenotypes , 2004, Plant Molecular Biology.